Late sodium current in human, canine and guinea pig ventricular myocardium
Introduction
Although late Na+ current (INa-late) is an important current flowing during the action potential (AP) plateau in mammalian cardiomyocytes with physiological and pathological significance recognized long ago [[1], [2], [3]], its pathophysiological role in LQT3 [4] and heart failure [[5], [6], [7], [8]] has been emphasized only in the last decades. INa-late - as an inward current - contributes to plateau formation and is responsible for largely half of the transmembrane Na+ entry [[9], [10], [11]]. As a consequence, the elevation of INa-late results in increased arrhythmia propensity (e.g. in heart failure) including prolongation of the action potential duration (APD), increased inhomogeneity of repolarization and occurrence of early as well as delayed afterdepolarizations [5,[12], [13], [14]]. Therefore, as a new concept, intensive efforts were made recently to develop selective inhibitors of INa-late [9,15,16].
Initially INa-late was believed to be a consequence of the overlapping steady-state activation and inactivation functions of the Na+ current (window Na+ current) [17], now it is better explained by the slow inactivation kinetics of a small fraction of cardiac Na+ channels (mode-II gating, bursting and late openings) [4,6]. In spite of its relative importance, many aspects of INa-late are still poorly understood. In contrast to the detailed data obtained in rabbit [18], guinea pig [19] and porcine [20] myocytes, we have only a limited number of recordings of native human and canine INa-late, since these experiments were typically performed using conventional voltage clamp arrangements and many of them at room temperature [7,8,[21], [22], [23]]. Self action potential voltage clamp measurements, delivering the cell's own AP as a command signal, are not available in the literature either for canine or human ventricular cardiomyocytes. Since canine ventricular cells are believed to be a good model for human ventricular myocytes in general regarding their cellular electrophysiological properties [[24], [25], [26]], our goal was to monitor and compare the profiles of INa-late in ventricular cells obtained from canine, guinea pig and undiseased human hearts. The rationale of our work is given by the very limited availibilty of undiseased human ventricular tissues for experimental purposes, and our results show that canine myocytes - but not guinea pig cells - are reasonably suitable preparations for studying the properties of human INa-late.
Section snippets
Preparations
Adult mongrel dogs of either sex (35 animals) were anesthetized with intramuscular injections of 10 mg/kg ketamine hydrochloride (Calypsol, Richter Gedeon, Hungary) + 1 mg/kg xylazine hydrochloride (Sedaxylan, Eurovet Animal Health BV, The Netherlands) according to a protocol approved by the local Animal Care Committee (license No: 9/2015/DEMÁB). All animal procedures conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific
Results
Primarily the optimal TTX concentration for dissection INa-late in canine ventricular myocytes had to be determined in order to find a TTX concentration that is suitable to excise a sufficiently large portion of INa-late allowing visualization of the true profile of the current. Representative records presented in Fig. 1.A indicate that the effect of TTX tends to saturate at the concentration of 10 μM. Based on the concentration-response curves obtained by fitting these data to the Hill
Discussion and conclusions
This is the first study to demonstrate the profiles of human and canine ventricular INa-late under self APVC conditions. From this perspective our results are in line with those of Murphy et al. [23] who have shown the profile of canine INa-late using canonic APs. Regarding undiseased human ventricular cells, this is the first report using the APVC technique. Our most important finding was to demonstrate that canine myocytes can be used as a reasonably good model to study human INa-late - in
Funding
This work was funded by the National Research Development and Innovation Office (NKFIH-K115397 to P.P.N, NKFIH-PD120794 and NKFIH-FK128116 to B.H. NKFIH-PD125402 and NKFIH-FK129117 to N.N., and NKFIH-K119992 to A.V.). Further support was obtained from the GINOP-2.3.2.-15-2016-00040 and EFOP-3.6.2-16-2017-00006 projects, which are co-financed by the European Union and the European Regional Development Fund. The work was also supported by the Hungarian Academy of Sciences (János Bolyai Research
Declaration of Competing Interest
None declared.
References (43)
Voltage-dependent block by tetrodotoxin of the sodium channel in rabbit cardiac Purkinje fibers
Biophys. J.
(1987)- et al.
Gating of the late Na+ channel in normal and failing human myocardium
J. Mol. Cell. Cardiol.
(2002) - et al.
Wolff MR et al. increased late sodium current in myocytes from a canine heart failure model and from failing human heart
J. Mol. Cell. Cardiol.
(2005) - et al.
β-Adrenergic regulation of late Na+ current during cardiac action potential is mediated by both PKA and CaMKII
J. Mol. Cell. Cardiol.
(2018) - et al.
Dynamics of the late Na+ current during cardiac action potential and its contribution to afterdepolarizations
J. Mol. Cell. Cardiol.
(2013) - et al.
Ca2+-activated Cl− current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization
J. Mol. Cell. Cardiol.
(2017) - et al.
Profile of L-type Ca2+ current and Na+/Ca2+ exchange current during cardiac action potential in ventricular myocytes
Heart Rhythm.
(2012) - et al.
Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity
Heart Rhythm.
(2014) - et al.
About half of the late sodium current in cardiac myocytes from dog ventricle is due to non-cardiac-type Na+ channels
J. Mol. Cell. Cardiol.
(2012) - et al.
Effect of tetrodotoxin on action potentials of the conducting system in the dog heart
Am. J. Phys.
(1979)
Slow inactivation of sodium current and voltage-dependent block by tetrodotoxin in rabbit cardiac Purkinje fibers
Biomed. Biochim. Acta
Sodium channel biophysics, late sodium current and genetic arrhythmic syndromes
Pflügers Arch.
The late sodium current in heart failure: pathophysiology and clinical relevance
ESC Heart Failure
Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability
Eur. J. Heart Fail.
Basal late sodium current is a significant contributor to the duration of action potential of guinea pig ventricular myocytes
Physiol. Rep.
A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes
Cardiovasc. Res.
Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload
Heart
The late Na+ current - origin and pathophysiological relevance
Cardiovasc. Drugs Ther.
The antiarrhythmogenic consequences of increasing late INa in the cardiomyocyte
Cardiovasc. Res.
Late sodium current associated cardiac electrophysiological and mechanical dysfunction
Pflügers Arch.
The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis
J. Cardiovasc. Electrophysiol.
Cited by (21)
Ion current profiles in canine ventricular myocytes obtained by the “onion peeling” technique
2021, Journal of Molecular and Cellular CardiologyCitation Excerpt :This problem was resolved by the introduction of the action potential voltage clamp technique (APVC, first applied by Fischmeister in 1984 [1]), which is based essentially on pharmacological current dissection using the original AP waveform of the cell as a command signal. The APVC technique was successfully applied in a variety of mammalian cardiac cells, including rats [2], pigs [3,4], rabbits [2,3,5,6,7], guinea pigs [8,9,10,11,12,13,14,15], dogs [16,17,18,19,20] and humans [21,22,23,24]. Despite the abundance of APVC data, little attempt was made to study the correlation of various ion current densities within the same cell.
Mitochondrial Ca<sup>2+</sup>, redox environment and ROS emission in heart failure: Two sides of the same coin?
2021, Journal of Molecular and Cellular CardiologyCitation Excerpt :Two small clinical trials with eleclazine and ranolazine, however, failed to prove the efficacy of these treatments and ended prematurely [146,147] although these results should be interpreted with caution because of the small numbers of patients studied. For a current detailed report on the role and properties of INaL we refer the readers to [148]. The cardiac NHE has been recognized for many years as a central regulator of intracellular pH (pHi) and Na+i [133,134].